Asthma is a serious health and economic concern worldwide. Recent studies indicate the role of vagal sensory neurons in the pathogenesis of asthma; however, the underlying molecular and cellular mechanisms are unclear. Recently we found that MrgprC11, a previously identified itch receptor in the skin nerves, is expressed in a subset of vagal sensory neurons innervating the airway. Bam8-22, a potent agonist of MrgprC11, induces cholinergic bronchoconstriction in WT mice, but not in knockout mice in which MrgprC11 was deleted. Administration of Bam8-22 can also enhance airway sensitivity to bronchoconstrictors in the absence of airway inflammation, suggesting the role of MrgprC11+ neurons in airway hyperresponsiveness. We have generated a BAC transgenic mouse line MrgprC11CreER to express inducible Cre DNA recombinase in MrgprC11+ neurons. In this proposal, we will use molecular, cellular, immunohistochemical and genetic approaches combined with a novel calcium imaging technique to elucidate the function of MrgprC11+ vagal sensory neurons in the airway and investigate their role in asthma.
Aim 1 will focus on the anatomical analysis of the axonal innervation pattern of MrgprC11+ vagal sensory neurons using genetic labeling tools.
In Aim 2, we will identify the endogenous/exogenous agonists for MrgprC11+ vagal sensory neurons to characterize the physiological properties of these neurons.
In Aim 3, we will determine the contribution of MrgprC11+ vagal sensory neurons in a mouse allergic asthma model. We will test our hypothesis that MrgprC11+ vagal sensory neurons exhibit hypersensitivity in allergic airway inflammation and play a role in the development of airway hyperresponsiveness. These studies will advance our understanding of the neural basis underlying asthma symptoms and will have significant impact on the clinical treatment of asthma.

Public Health Relevance

Asthma is a chronic inflammatory disease of the airway affecting more than 400 million people worldwide. Our research suggest that vagal sensory neurons expressing MrgprC11 contribute to asthma phenotypes. Analysis of these neurons will expand our knowledge of the pathogenesis of asthma and possibly lead to novel therapeutics for treating asthma.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
1R01HL141269-01
Application #
9496542
Study Section
Respiratory Integrative Biology and Translational Research Study Section (RIBT)
Program Officer
Lachowicz-Scroggins, Marrah Elizabeth
Project Start
2018-04-01
Project End
2023-03-31
Budget Start
2018-04-01
Budget End
2019-03-31
Support Year
1
Fiscal Year
2018
Total Cost
Indirect Cost
Name
Georgia Institute of Technology
Department
Biology
Type
Schools of Arts and Sciences
DUNS #
097394084
City
Atlanta
State
GA
Country
United States
Zip Code
30318